Search

everythinglearnresearchcommunity

for

Search:↓

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

HPDAlR nanoparticles greatly improve skin wound healing without toxicity.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

Cyproterone acetate reduced hair growth in most hirsute females and made hair softer, thinner, and lighter.

Dupilumab can help regrow hair in alopecia areata but stopping it may cause hair loss again.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

The multi-injection plate is a less painful and more efficient method for treating patchy hair loss.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

The nanocrystalline suspension effectively delivers dutasteride over time with minimal inflammation.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Intralesional triamcinolone effectively reduces pain and inflammation in hidradenitis suppurativa flares.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

Topical alpha-terthienyl with UVA may safely treat psoriasis without cancer risk.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

A reliable method was developed to measure Finasteride and Tadalafil in rat blood.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Isotretinoin is recommended for acne treatment as it is as effective as cyproterone compound.

Tofacitinib is an effective and safe treatment for alopecia areata.